February 18, 2026 · Form 4 insider transaction
NEWHALL CHARLES W III bought 4,977 shares of Supernus Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Each option vests on February 18, 2027.